Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NAFISA NOORUDDIN BHAI

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1710685185
CMS profile
11515458
Location
SUGAR LAND, TX

General Payments · PY2023–2024

$622.89

  • Reported across 20 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$574.56

18 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $433.57 16
Education $140.99 2

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $48.33 2
PY2024 $574.56 18

Payment records · PY2024 (18)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $15.21 10/24/2024 Food and Beverage Undisputed 01/23/2026 1117507094 CMS
Amneal Pharmaceuticals LLC $19.17 01/24/2024 Food and Beverage Undisputed 01/23/2026 1139207468 CMS
Aveo Pharmaceuticals, Inc. $40.55 01/31/2024 Food and Beverage Undisputed 01/23/2026 1143497424 CMS
Aveo Pharmaceuticals, Inc. $32.88 04/18/2024 Food and Beverage Undisputed 01/23/2026 1143497430 CMS
Azurity Pharmaceuticals, Inc. $19.50 08/28/2024 Food and Beverage Undisputed 01/23/2026 1134015563 CMS
Daiichi Sankyo Inc. $0.39 02/07/2024 Food and Beverage Undisputed 01/23/2026 1089400033 CMS
Daiichi Sankyo Inc. $22.71 02/07/2024 Food and Beverage Undisputed 01/23/2026 1089400035 CMS
Daiichi Sankyo Inc. $16.90 09/04/2024 Food and Beverage Undisputed 01/23/2026 1089400029 CMS
Daiichi Sankyo Inc. $99.00 10/04/2024 Education Undisputed 01/23/2026 1089400031 CMS
Janssen Biotech, Inc. $24.33 05/07/2024 Food and Beverage Undisputed 01/23/2026 1078770487 CMS
Janssen Biotech, Inc. $21.70 06/12/2024 Food and Beverage Undisputed 01/23/2026 1078769641 CMS
Janssen Biotech, Inc. $108.49 08/21/2024 Food and Beverage Undisputed 01/23/2026 1078771146 CMS
Janssen Biotech, Inc. $19.67 09/11/2024 Food and Beverage Undisputed 01/23/2026 1078769979 CMS
Novartis Pharmaceuticals Corporation $24.76 07/17/2024 Food and Beverage Undisputed 01/23/2026 1086751221 CMS
PFIZER INC. $23.70 01/11/2024 Food and Beverage Undisputed 01/23/2026 1131138234 CMS
SANOFI-AVENTIS U.S. LLC $41.99 06/21/2024 Education Undisputed 01/23/2026 1139986958 CMS
SHIELD THERAPEUTICS INC $21.15 08/07/2024 Food and Beverage Undisputed 01/23/2026 1150140932 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.46 07/03/2024 Food and Beverage Undisputed 01/23/2026 1144972110 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.